Surgical treatment of intracranial malignant melanoma: an anlysis of 7 cases
10.3760/cma.j.cn115354-20200502-00329
- VernacularTitle:颅内恶性黑色素瘤的外科治疗体会(附七例报道)
- Author:
Yinxing HUANG
1
;
Jiaxing WANG
;
Jun TIAN
;
Mingchao SHANG
;
Shousen WANG
Author Information
1. 解放军联勤保障部队第九〇〇医院，福建医科大学福总临床医学院神经外科，福州 350025
- Keywords:
Malignant melanoma;
Intracranial metastasis;
Surgical treatment
- From:
Chinese Journal of Neuromedicine
2020;19(8):820-824
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the surgical treatment efficacy and experience of intracranial malignant melanoma (IMM).Methods:Seven patients with IMM, including 3 with primary IMM and 4 with secondary IMM, admitted to our hospital from May 2013 to June 2018, were treated with minimally invasive transcranial surgery. The tumors were removed as much as possible during the operation; according to the postoperative condition of these patients, adjuvant therapies such as follow-up or radiotherapy/chemotherapy, or/and reoperation/comprehensive treatment were provided.Results:These 7 patients eventually died; among the 3 patients with primary IMM, one had total resection, one had subtotal resection, and one had partial resection, and the postoperative survival period was 10 months, 7 months and one month, respectively; among the 4 patients with secondary IMM, three had total resection, and one had partial resection, and the postoperative survival period was 32 months, 13 months, 12 months and 5 month, respectively.Conclusion:The overall prognosis of IMM patients is poor, and surgical removal of the primary and intracranial lesions is the key to prolong survival.
